The chart was, in truth, a parody of analysis. Even the presenter acknowledged it was unlikely. But that was never the point. The intent was to frame stakeholder calls for greater investment in innovative health technologies as a direct threat to national solvency. The underlying message was clear. The demand is against the national interest. …
The continued 'false framing' aims to make us feel guilty for wanting more on health
October 31, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The 'Dispatched' Week in Review' Podcast - 4 September
September 4, 2026 - - Podcast -
A three-pronged expansion of Commonwealth reach in therapeutic-goods regulation
September 4, 2026 - - Latest News -
If the government gives itself more power, don't be surprised when they use it
September 4, 2026 - - Latest News -
Medicines Australia calls for doubling of PBS medicines investment
September 4, 2026 - - Latest News -
Gilead returns to Medicines Australia as industry prepares to make the case for innovation
September 3, 2026 - - Latest News -
Combined monitoring of key indicators as the future of diabetes care
September 3, 2026 - - Latest News -
The live lesson from the UK on who holds the levers and how they use them
September 3, 2026 - - Latest News